Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Heron Therapeutics (HRTX) over the last 16 years, with Dec 2024 value amounting to $9.9 million.

  • Heron Therapeutics' Other Working Capital Changes rose 36.81% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1059.50%. This contributed to the annual value of $9.9 million for FY2024, which is 164.35% up from last year.
  • Latest data reveals that Heron Therapeutics reported Other Working Capital Changes of $9.9 million as of FY2024, which was up 164.35% from -$15.4 million recorded in FY2023.
  • In the past 5 years, Heron Therapeutics' Other Working Capital Changes ranged from a high of $9.9 million in FY2024 and a low of -$15.4 million during FY2023.
  • In the last 3 years, Heron Therapeutics' Other Working Capital Changes had a median value of -$1.0 million in 2022 and averaged -$2.2 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 747.57% in 2021, then slumped by 1,427.33% in 2023.
  • Heron Therapeutics' Other Working Capital Changes (Yearly) stood at -$1.3 million in 2020, then skyrocketed by 747.57% to $8.4 million in 2021, then plummeted by 112.04% to -$1.0 million in 2022, then plummeted by 1,427.33% to -$15.4 million in 2023, then skyrocketed by 164.35% to $9.9 million in 2024.